Literature DB >> 23503772

The number of cysteine residues per mole in apolipoprotein E affects systematically synchronous neural interactions in women's healthy brains.

Arthur C Leuthold1, Margaret Y Mahan, John J Stanwyck, Angeliki Georgopoulos, Apostolos P Georgopoulos.   

Abstract

Apolipoprotein E (apoE) is involved in lipid metabolism in the brain, but its effects on brain function are not understood. Three apoE isoforms (E4, E3, and E2) are the result of cysteine-arginine interchanges at two sites: there are zero interchanges in E4, one interchange in E3, and two interchanges in E2. The resulting six apoE genotypes (E4/4, E4/3, E4/2, E3/3, E3/2, E2/2) yield five groups with respect to the number of cysteine residues per mole (CysR/mole), as follows. ApoE4/4 has zero cysteine residues per mole (0-CysR/mole), E4/3 has one (1-CysR/mole), E4/2 and E3/3 each has two (2-CysR/mole), E3/2 has three (3-CysR/mole), and E2/2 has four (4-CysR/mole). The use of the number of CysR/mole to characterize the apoE molecule converts the categorical apoE genotype scale, consisting of 6 distinct genotypes above, to a 5-point continuous scale (0-4 CysR/mole). This allows the use of statistical analyses suitable for continuous variables (e.g. regression) to quantify the relations between various variables and apoE. Using such analyses, here, we show for the first time that apoE affects in a graded and orderly manner neural communication, as assessed by analyzing the relation between the number of CysR/mole and synchronous neural interactions (SNI) measured by magnetoencephalography (MEG) in 130 cognitively healthy women. At the one end of the CysR/mole range, the 4-CysR/mole (E2/2) SNI distribution had the highest mean, lowest variance, lowest range, and lowest coefficient of variation, whereas at the other end, 0-CysR/mole (E4/4) SNI distribution had the lowest mean, highest variance, highest range, and highest coefficient of variation. The special status of the 4-CysR/mole distribution was reinforced by the results of a hierarchical tree analysis where the 4-CysR/mole (E2/2) SNI distribution occupied a separate branch by itself and the remaining CysR/mole SNI distributions were placed at increasing distances from the 4-CysR/mole distribution, according to their number of CysR/mole, with the 0-CysR/mole (E4/4) being farthest away. These findings suggest that the 4-CysR/mole (E2/2) SNI distribution could serve as a reference distribution. When the SNI distributions of individual women were expressed as distances from this reference distribution, there was a substantial overlap among women of various CysR/mole. This refocuses the placement of individual brains along a continuous distance from the 4-CysR/mole SNI distribution, in contrast to the common categorical assignment to a specific apoE genotype. Finally, the orderly variation of SNI with the number of CysR/mole found here is in keeping with recent advances and ideas regarding the molecular mechanisms underlying the differential effects of apoE in the brain which emphasize the healthier stability conferred on the apoE molecule by the increasing number of cysteine-arginine interchanges, with 4-CysR/mole (E2/2) being the best case, as opposed to the instability and increased chance of toxic fragmentation of the apoE molecule with lower number of CysR/mole, with 0-CysR/mole (E4/4) as the worst case (Mahley and Huang in Neuron 76:871-885, 2012a). However, our results also document the appreciable variation of SNI properties within the various CysR/mole groups and individuals which points to the existence and important role of other factors involved in shaping brain function at the network level.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23503772     DOI: 10.1007/s00221-013-3464-x

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  76 in total

1.  Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEepsilon4 in young healthy adults.

Authors:  Francesca M Filbey; Kelly J Slack; Trey P Sunderland; Robert M Cohen
Journal:  Neuroreport       Date:  2006-10-23       Impact factor: 1.837

Review 2.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

3.  Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia.

Authors:  L Gustafson; M Abrahamson; A Grubb; K Nilsson; G Fex
Journal:  Dement Geriatr Cogn Disord       Date:  1997 Jul-Aug       Impact factor: 2.959

4.  Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.

Authors:  K H Weisgraber; S C Rall; R W Mahley
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

5.  The synchronous neural interactions test as a functional neuromarker for post-traumatic stress disorder (PTSD): a robust classification method based on the bootstrap.

Authors:  A P Georgopoulos; H-R M Tan; S M Lewis; A C Leuthold; A M Winskowski; J K Lynch; B Engdahl
Journal:  J Neural Eng       Date:  2010-01-20       Impact factor: 5.379

6.  Cerebral cortical mechanisms of copying geometrical shapes: a multidimensional scaling analysis of fMRI patterns of activation.

Authors:  Charidimos Tzagarakis; Trenton A Jerde; Scott M Lewis; Kâmil Uğurbil; Apostolos P Georgopoulos
Journal:  Exp Brain Res       Date:  2009-02-03       Impact factor: 1.972

7.  Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study.

Authors:  S H Han; G Einstein; K H Weisgraber; W J Strittmatter; A M Saunders; M Pericak-Vance; A D Roses; D E Schmechel
Journal:  J Neuropathol Exp Neurol       Date:  1994-09       Impact factor: 3.685

8.  Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease.

Authors:  R Benjamin; A Leake; P G Ince; R H Perry; I G McKeith; J A Edwardson; C M Morris
Journal:  Neurodegeneration       Date:  1995-12

Review 9.  Apolipoprotein e sets the stage: response to injury triggers neuropathology.

Authors:  Robert W Mahley; Yadong Huang
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

10.  Expression of apolipoprotein E during nerve degeneration and regeneration.

Authors:  M J Ignatius; P J Gebicke-Härter; J H Skene; J W Schilling; K H Weisgraber; R W Mahley; E M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

View more
  6 in total

1.  Departure from Network Equilibrium (DNE): an efficient and scalable measure of instantaneous network dynamics, with an application to magnetoencephalography.

Authors:  Margaret Y Mahan; Arthur C Leuthold; Apostolos P Georgopoulos
Journal:  Exp Brain Res       Date:  2013-10-24       Impact factor: 1.972

2.  The effect of apolipoprotein E4 on synchronous neural interactions in brain cultures.

Authors:  Vassilios Christopoulos; Angeliki Georgopoulos; Apostolos P Georgopoulos
Journal:  Exp Brain Res       Date:  2015-04-14       Impact factor: 1.972

3.  Apolipoprotein E: the resilience gene.

Authors:  Lisa M James; Brian E Engdahl; Apostolos P Georgopoulos
Journal:  Exp Brain Res       Date:  2017-03-15       Impact factor: 1.972

4.  Gulf War illness (GWI) as a neuroimmune disease.

Authors:  Apostolos P Georgopoulos; Lisa M James; Adam F Carpenter; Brian E Engdahl; Arthur C Leuthold; Scott M Lewis
Journal:  Exp Brain Res       Date:  2017-07-31       Impact factor: 1.972

5.  Brain Correlates of Human Leukocyte Antigen (HLA) Protection in Gulf War Illness (GWI).

Authors:  Lisa M James; Brian E Engdahl; Arthur C Leuthold; Apostolos P Georgopoulos
Journal:  EBioMedicine       Date:  2016-10-14       Impact factor: 8.143

6.  The effects of human leukocyte antigen DRB1*13 and apolipoprotein E on age-related variability of synchronous neural interactions in healthy women.

Authors:  Lisa M James; Stacy Dolan; Arthur C Leuthold; Brian E Engdahl; Angeliki Georgopoulos; Apostolos P Georgopoulos
Journal:  EBioMedicine       Date:  2018-08-20       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.